188 related articles for article (PubMed ID: 28333141)
1. NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A.
Yuan P; Li J; Zhou F; Huang Q; Zhang J; Guo X; Lyu Z; Zhang H; Xing J
Cell Death Dis; 2017 Mar; 8(3):e2704. PubMed ID: 28333141
[TBL] [Abstract][Full Text] [Related]
2. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells.
Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
Cancer Lett; 2020 Jan; 469():498-509. PubMed ID: 31765736
[TBL] [Abstract][Full Text] [Related]
3. Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer.
Xue X; Liu F; Han Y; Li P; Yuan B; Wang X; Chen Y; Kuang Y; Zhi Q; Zhao H
Biochem Biophys Res Commun; 2014 Jul; 450(2):1058-62. PubMed ID: 24978311
[TBL] [Abstract][Full Text] [Related]
4. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
5. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways.
Huang Q; Zhan L; Cao H; Li J; Lyu Y; Guo X; Zhang J; Ji L; Ren T; An J; Liu B; Nie Y; Xing J
Autophagy; 2016 Jun; 12(6):999-1014. PubMed ID: 27124102
[TBL] [Abstract][Full Text] [Related]
6. Changes in pH and NADPH regulate the DNA binding activity of neuronal PAS domain protein 2, a mammalian circadian transcription factor.
Yoshii K; Tajima F; Ishijima S; Sagami I
Biochemistry; 2015 Jan; 54(2):250-9. PubMed ID: 25526362
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
8. Rock2 regulates Cdc25A through ubiquitin proteasome system in hepatocellular carcinoma cells.
Liu T; Yu X; Li G; Yuan R; Wang Q; Tang P; Wu L; Liu X; Peng X; Shao J
Exp Cell Res; 2012 Oct; 318(16):1994-2003. PubMed ID: 22705122
[TBL] [Abstract][Full Text] [Related]
9. MCUR1-Mediated Mitochondrial Calcium Signaling Facilitates Cell Survival of Hepatocellular Carcinoma via Reactive Oxygen Species-Dependent P53 Degradation.
Ren T; Wang J; Zhang H; Yuan P; Zhu J; Wu Y; Huang Q; Guo X; Zhang J; Ji L; Li J; Zhang H; Yang H; Xing J
Antioxid Redox Signal; 2018 Apr; 28(12):1120-1136. PubMed ID: 28938844
[TBL] [Abstract][Full Text] [Related]
10. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.
Ma S; Chen Y; Quan P; Zhang J; Han S; Wang G; Qi R; Zhang X; Wang F; Yuan J; Yang X; Jia W; Qin W
BMC Cancer; 2023 Mar; 23(1):280. PubMed ID: 36978001
[TBL] [Abstract][Full Text] [Related]
11. CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
Xu X; Yamamoto H; Liu G; Ito Y; Ngan CY; Kondo M; Nagano H; Dono K; Sekimoto M; Monden M
Int J Mol Med; 2008 Feb; 21(2):145-52. PubMed ID: 18204780
[TBL] [Abstract][Full Text] [Related]
12. Effects of NAD(P)H and its derivatives on the DNA-binding activity of NPAS2, a mammalian circadian transcription factor.
Yoshii K; Ishijima S; Sagami I
Biochem Biophys Res Commun; 2013 Aug; 437(3):386-91. PubMed ID: 23831463
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptor-mediated cell-autonomous oscillatory expression of the circadian transcription factor, neuronal PAS domain protein 2 (NPAS2).
Matsumura R; Matsubara C; Node K; Takumi T; Akashi M
J Biol Chem; 2013 Dec; 288(51):36548-53. PubMed ID: 24196956
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
[TBL] [Abstract][Full Text] [Related]
15. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
16. Direct regulation of diurnal Drd3 expression and cocaine reward by NPAS2.
Ozburn AR; Falcon E; Twaddle A; Nugent AL; Gillman AG; Spencer SM; Arey RN; Mukherjee S; Lyons-Weiler J; Self DW; McClung CA
Biol Psychiatry; 2015 Mar; 77(5):425-433. PubMed ID: 25444159
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
18. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
[TBL] [Abstract][Full Text] [Related]
19. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response.
Hoffman AE; Zheng T; Ba Y; Zhu Y
Mol Cancer Res; 2008 Sep; 6(9):1461-8. PubMed ID: 18819933
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
